.After antibody-drug conjugate (ADC) expert Seagen was sold to Pfizer in 2015 for a tremendous $43 b...
.On the heels of a phase 3 succeed that fell short to wow real estate investors, Ironwood Pharmaceut...
.Don't cease Monte Rosa Therapeutics now. The Boston-based biotech is having a ball after authorizin...
.Invite to today's Chutes & Ladders, our summary of significant management hirings, shootings as ...
.Commemorating his company's upsized initial public offering (IPO), Septerna CEO Jeffrey Finer calle...
.AbbVie has come back to the source of its antipsychotic giant Vraylar looking for one more smash hi...
.GenSight Biologics is weeks away from running out of cash. Once again. The biotech only has enough ...
.Monopar Therapies is actually bouncing back a medication coming from the dump of AstraZeneca's rare...
.Along with brand new information out on Arcus Biosciences' experimental HIF-2a inhibitor, one group...
.After developing a gene therapy collaboration with Dyno Therapeutics in 2020, Roche is back for eve...
.Lundbeck is actually lowering the book value of its own $250 million Abide Therapeutics acquistion ...
.The combination of real-world data (RWD) in to process usefulness and also website option has becom...
.At this year's Intense Biotech Summit in Boston, our company caught up with leaders in the biotech ...
.Merck & Co. is actually putting down $30 thousand upfront to buy Yale spinout Modifi Biosciences...
.Alpha-9 Oncology has actually elevated a $175 thousand set C round to bankroll its own clinical-sta...
.Eye medicine manufacturer Ocuphire Pharma is actually obtaining genetics therapy creator Opus Genes...
.Roche's chronic cough course has actually faltered to a standstill. The drugmaker, which axed the s...
.Gilead Sciences and also Merck & Co. have actually directed their once-weekly HIV combo treatmen...
.Lykos Therapeutics may possess lost three-quarters of its own team back the FDA's rejection of its ...
.Septerna might be as yet to reveal "any type of significant professional information," however the ...